Earlier we wrote about the GeNO Nitrosyl NO Delivery Device. However, a rep for the company has written in with a clarification that the image we showed was not the device cleared for investigative use. The stand-alone gas cylinder pictured is what was approved.
Here’s from an email sent to us by a representative for GeNO LLC:
the ambulatory (belt-clip sized) system is one of 3 Nitrosyl platforms and has not entered trials or the clinical setting yet: there is
1) the stand alone gas cylinder (which just got the IND cleared and will enter (phase) 2, first as a diagnostic in pulmonary arterial hypertension, per the release and my note);
2) a ventilator system; and
3) the ambulatory system. From the lead I just did not want confusion that the system in the photo is what we issued in our IND release– that system is a downstream technology in the various Nitrosyl platforms.
…the portable size is very interesting given all of the treatment difficulties you describe, I just wanted to be clear that GeNO is starting first with the stand-alone gas cylinder in trials (recent IND cleared), and this is exciting because it opens the door to further resarch and allows GeNO to move their other technologies and platforms (like the ambulatory) into development.
Flashback:GeNO Nitrosyl NO Delivery Device Moves to Phase 2 Testing…
